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1. Summary 
 
Oxygen homeostasis in cells and tissues is tightly controlled by the transcription 
factors Hypoxia Inducible Factors (HIFs) which regulate the expression of genes 
that facilitate O2 delivery and metabolic adaptation to O2 deprivation in all 
mammalian cells (Semenza, 2001). Therefore, HIFs ensure the cells‟ survival by 
playing a dominant role in response to ischemia, anemia or systemic hypoxia 
(Berchner-Pfannschmidt et al., 2008). Three isoforms of HIF-α subunits HIF-1α, 
HIF-2α and HIF-3α differ by their specific sources; however they share highly 
similar structures (Gu et al., 1998). Because of the frequent presence of HIF-1α 
and HIF-2α, as well the less well understood role of HIF-3α (Loboda et al., 
2010), the focus of this study was HIF-1α and HIF-2α. Controlling the 
expression of several hundreds of HIF target genes involved in O2 transport 
(erythropoietin), angiogenesis, glucose metabolism, proliferation and survival 
(Rankin et al., 2008), HIF-1α and HIF-2α were intensively studied in recent 
years. However, neither the physiology nor the pathophysiology is fully resolved 
as “master regulators of oxygen homeostasis” (Semenza, 1998). To obtain better 
understanding of the HIFs‟ regulation, confocal microscopic fluorescence 
resonance energy transfer (FRET) was applied for investigating the protein-
protein interaction between the subunits. In order to show the function of basic 
helix-loop-helix (bHLH) and Period/Arnt/Single-minded (PAS) domains, 
deletion and single nucleotide mutations were performed on HIF-1α and HIF-
2α.  It is evident that a basis to explain some of the target gene specificity 
observed with HIF-1 versus HIF-2 driven genes can be provided by the new 
findings in this study. 
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2. Introduction 
 
2.1 Structure of Hypoxia Inducible Factors (HIFs) 
HIF is expressed ubiquitously as a heterodimer (Semenza, 1996) consisting of α- 
(human HIF-1α: 826 amino acids, 120 kD; human HIF-2α: 870 amino acids, 
118 kD; Lau et al., 2007) and the β-subunit (human HIF-1β: 774-789 amino 
acids, 91-94 kD) also known as aryl hydrocarbon nuclear translocator (ARNT; 
Wang et al., 1995). All subunits belong to the bHLH (basic helix-loop-helix) 
PAS (Period/Arnt/Single-minded) transcription factor family (Wang et al., 
1995). These two N-terminal located bHLH- and PAS-domains are essential for 
the formation of α/β heterodimers and sequence-specific DNA binding (Gu et 
al., 2000). The following ODD domain (oxygen-dependent degradation domain) 
and the N-TAD domain (N-terminal transactivation domain), only present in α-
subunits (Fig. 2-1), are recognized by PHD 1-3 (prolyl hydroxylase-domains 1-
3) for O2-dependent hydroxylation and targeting for subsequent degradation by 
the proteasomes (Fandrey et al., 2006). The lack of the ODD and N-TAD in 
ARNT causes its constitutive expression in the cell nucleus. The C-TAD domain 
(C-terminal transactivation domain), acts to recruit transcriptional co-regulatory 
proteins like p300/CBP and is shared both in α-subunits (Fig. 2-1; Fandrey et 
al., 2009). These structural characteristics are shared to a high degree by the 
HIF-1α and HIF-2α isoforms: 85 % in the bHLH domain, 70 % in the PAS 
domain, 69 % in the ODD domain, 70 % in the N-TAD domain and 69 % in the 
C-TAD domain are identical (Hu et al., 2007).  
In this study, the function of bHLH and PAS domains were determined. The 
bHLH domain, consisting of 60 amino acids, is composed of an N-terminal 
basic region functioning for DNA binding, and a C-terminal HLH region 
involve in dimerization (Murre et al., 1994; Fig. 2-2 A). The interaction between 
the HLH regions of two separate polypeptides leads to the formation of 
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homodimers and/or heterodimers and subsequent specific DNA-sequence 
recognition (Carretero-Paulet et al., 2010). The following PAS domain is 
widespread as signal transduction proteins, currently identified in 2000 proteins 
from organisms in all three kingdoms of life and is further subdivided into a 
PAS A- (N-terminal) and a PAS B- (more C-terminal) domain within the entire 
PAS stretch (Möglich et al., 2009). Usually, PAS consists of about 120 amino 
acids. A five-stranded antiparallel β-sheet structure was determined to be 
required for hetero- and homodimerization (Card et al., 2005; Fig. 2-2 B).  
 
 
 
 
 
 
Fig. 2-1: Structure of hypoxia inducible factors 
HIF-1α, HIF-2α and ARNT locate in human gene chromosome 14, 2, and 1, respectively 
(Szablowska-Gadomska et al., 2011). bHLH and PAS domains are responsible for DNA 
binding and dimerization. ODD and N-TAD domains, present only in α-subunits, serve as 
targets for hydroxylation at their proline residues. C-TAD possesses a p300/CBP binding site 
for the transactivation. 
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Fig. 2-2: Structure of bHLH (A) and PAS (B)  
(A) Structural, bHLH domain is responsible for DNA-binding (N-terminal basic region) and 
dimerization (C-terminal HLH region; modified from Michel et al., 2000). (B) PAS, 
contributing for dimerization, consists of PAS-A and PAS-B domains with anti-parallel 
structure, provided by two molecules (modified from Chowdhury et al., 2008). 
 
2.2 Oxygen Dependent Activation of HIF 
In normoxic condition, both HIF-1α and HIF-2α subunits are rapidly post-
translationally hydroxylated at proline residues (HIF-1α: P402 and P564, HIF-
2α: P405 and P531) by oxygen sensitive enzymes with prolyl hydroxylase-
domains (PHD 1, 2 and 3; Jaakkola et al., 2001, Ivan et al., 2001 and Bruick, 
McKnight, 2001). The activity of PHDs is dependent on oxygen, therefore the 
PHDs are called cellular oxygen sensor (Berchner-Pfannschmidt et al., 2008). 
Moreover, the co-substrate 2-oxoglutarate, iron (II) cofactors and vitamin C are 
required for the hydroxylation of HIF-α subunits (Nytko et al., 2011). 
Hydroxylated HIF-αs are recognized by the von-Hippel-Lindau protein, rapidly 
polyubiquitinylated and degraded by 26S proteasome (Schofield et al., 2005 and 
Fandrey et al., 2006). Thus, HIF-αs are undetectable in most cells under well 
oxygenated conditions; however in hypoxia, PHD activity ceases (Berchner-
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Pfannschmidt et al., 2007), which makes the hydroxylation infeasible, so that 
the stabilized HIF-α subunits accumulate and translocate into nuclear through 
their NLS (nuclear localization sequence) at the N-terminal end of α-subunits. 
Then, HIF-α subunits dimerize with the constitutively expressed ARNT subunit 
in the nucleus. The interaction takes place via the bHLH and PAS domains and a 
functional DNA-binding complex is formed. This then specifically binds the 
well conserved HIF binding site (HBS) within hypoxia response elements 
(HRE) 5'-NCGTG-3' (wherein N is either A or G) and leads to transcription of 
the corresponding target genes, such as carbonic anhydrase 9 (CA9), vascular 
endothelial growth factor (VEGF), adrenomedullin (ADM) and erythropoietin 
(EPO; Semenza, 2001). In addition to the degradation of the α-subunit under 
normoxia, the transcriptional activity of HIF can be blocked by hydroxylation of 
an asparagine residue in the C-terminal transactivation domain (C-TAD), since 
the recruitment of transcriptional cofactor p300/CBP (cAMP response element 
binding protein) is prevented by asparagine hydroxylase called factor inhibiting 
HIF-1 (FIH-1; Fandrey et al., 2006). 
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Fig. 2-3: HIF-α mediated pathway of O2 sensing 
HIF-αs accumulate in hypoxia (pathway with red arrows) and translocate into nuclear to 
dimerize with ARNT. Heterocomplexes bind to hypoxia response elements (HRE) of DNA to 
induce HIF target genes. In normoxia (pathway with yellow arrows), α-subunits are rapidly 
hydroxylated, ubiquitinylated and degraded in the proteasome. 
 
2.3 HIF-1α and HIF-2α 
The structural similarity of the two isoforms HIF-1α and HIF-2α was shown in 
Fig. 2-1. However, they differ by their cellular localization, oxygen dependent 
degradation, transcriptional coactivation, a variety of target genes and even the 
pathological functions (Ratcliffe, 2007). HIF-1α is ubiquitously expressed in all 
cells whereas HIF-2α is limited to endothelium, kidney, lung, heart and small 
intestine (Gordan et al., 2007). From the first discovery of HIF-1α by Semenza 
in 1996, over hundreds of HIF-1α target genes have been already identified, 
whereas the selective HIF-2α responsive genes were only found recently 
(Covello et al., 2006 and Raval et al., 2005). Some target genes like VEGF are 
shared both by HIF-1α and HIF-2α, however, others like EPO is preferentially 
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regulated by HIF-2α in kidney and liver (Rankin et al., 2007). Furthermore, the 
proapoptotic gene BCL2/adenovirus E1B-interacting protein 1, (NIP3/Bnip3) 
and a series of gene encoding enzymes involved in the glycolytic pathway as 
PGK (phosphoglycerate kinase) are characterized as preferential HIF-1α targets 
(Hu et al., 2003; Raval et al., 2005). The distinct, tissue specific target genes 
raise the question about how the HIF-1α and HIF-2α are working together in 
hypoxia. The knockout of both subunits is lethal (Huang and Bunn, 2003). 
Moreover, HIF-2α affects the vascular function and angiogenesis in vascular 
endothelial cells (Skuli et al., 2009), promotes growth and metastasis in 
neuroblastomas (Holmquist-Mengelbier et al., 2006). HIF-2α is involved in the 
genesis of renal carcinoma with the von Hippel-Lindau syndrome (Kondo et al., 
2003), however it inhibited the growth of breast cells (Blancher et al., 2000), in 
which the HIF-1α is required for induction with a set of well-characterized 
hypoxic genes (Sowter et al., 2003). Recent data of Yuan et al. provided 
evidence that the mutual antagonism between HIF-1α and HIF-2α may be 
through the regulation of ROS (reactive oxygen species; Yuan et al., 2012). All 
these facets make the understanding of the molecular regulation of HIF-1α and 
HIF-2α eminently important. 
 
2.4 Aim of the Study 
In this study, we examined hetero- and homodimerization of HIF-subunits using 
fluorescence resonance energy transfer (FRET). To understand the molecular 
function of bHLH and PAS domains, deletions and single nucleotide mutations 
were performed. Labeling of HIF subunits with cyano fluorescent protein (CFP) 
and yellow fluorescent protein (YFP) allowed the identification in the 
microscopic study and provided the basis for FRET (Fig. 2-4). In addition, co-
immunoprecipitation was performed to confirm the FRET results. Electro-
Mobility-Shift-Assays (EMSA) were carried out to test for potential DNA-
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binding of homodimers and the activity was determined by activation of a HIF-1 
driven luciferase reporter gene and quantitation of target gene expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-4: Fluorescent protein-HIF fusion protein constructs used in this study 
Wildtype (the top section), bHLH-deleted (the middle section) and PAS-mutant (triple dots 
mutation and PASAB-deletion, the bottom section) HIF-subunits were generated and applied. 
For FRET study, all constructures were labeled with fluorescence proteins (CFP or YFP). 
Constructs in detail see table 3-17. 
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PAS-mutations: 
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3. Materials and Methods 
 
3.1 Cell Culture of the Eukaryotic Cells 
The cell line U2OS (osteosarcoma, ATCC No. HTB-96) was used for the whole 
study. U2OS were grown as monolayer in the cell culture with medium DMEM 
(Dulbecco's Modified Eagle's Medium, Gibco) with 10 % FCS, 100 U/ml 
penicillin and 100 U/ml Streptomycin sulfate (Gibco). Cells were incubated in 
75 cm
2
 culture flask with 5 % CO2 in air and 100 % humidity in 37 °C incubator. 
The medium was replaced every 3 days. 
 
 
Fig. 3-1: Schema of cell flask and medium 
Cells were cultured in flask (Cellstar
®
) with 15 ml medium (DMEM, Gibco). 
 
3.2 Protein-Biological Methods 
Generation of Cell Lysates 
0.2-0.8105, 1-3105, 1-3105 and 5-10105 cells were plated on 24-well plates 
(for luciferase reporter gene assay), 6-well plates (for Western blot), 35 mm 
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diameter dishes (for FRET) and 60 mm dishes (for Electro-Mobility-Shift-Assay 
and co-immunoprecipitation) respectively (50-60 % cellular confluence) and 
incubated for 1 day for further experiments. To generate the cell lysate, cell 
culture medium was removed and all plates and dishes were rinsed with cold 
PBS buffer placed on ice. Immediately, 50 l lysis buffer (50 l Igepal (0.1 % 
NP40), 30 ml 0.5 M sodium chloride, 500 l 1 M Tris pH 7.9, 100 l 0.5 M 
EDTA, 18.9 ml 1PBS) with 10 % protein inhibitor was added to the cells for 
Western blot analysis and 500 l lysis buffer (1 % NP40, 0.15 M sodium 
chloride, 2 mM EDTA, 10 mM sodium phosphate, pH 7.2) with 10 % protein 
inhibitor was added to the cells for co-immunoprecipitation. Using a cell 
scraper, the cells were removed from the bottom of the dishes and transferred to 
an 1.5 ml Eppendorf tube. After incubation on ice for 20 min, supernatant was 
separated from the cell debris through centrifugation at 3600 rpm at 4 °C for 
5 min. 5 l supernatant was needed for protein determination and the rest was 
stored at -20 °C for further study. 
 
Protein Determination 
Protein concentration was determined in whole cell lysates with the Dc protein 
assay kit (BioRad). The prepared 5 l lysate was diluted with deionized water to 
a final volume of 50 l. 20 l was pipetted onto a 96 well plate for protein 
determination in duplicate. To each well, 10 l reagent A (containing sodium 
carbonate, sodium bicarbonate, bicinchoninic acid and sodium tartrate in 0.1 M 
sodium hydroxide) and 75 µl reagent B (containing 4 % cupric sulfate) were 
added. Simultaneously, standard series of albumin (25, 10, 5, 2.5, 1, 0.5, 0.25 
and 0.1 mg/ml) and a water sample were treated in the same way. After 5 min 
incubation at room temperature, a blue color developed and the absorbance was 
measured at 700 nm  in the plate reader Epoch (BioTek) using the albumin as a 
standard. 
 
3. Materials and Methods  14 
 
SDS-PAGE and Western Blot 
Proteins were separated by SDS-PAGE under denaturing conditions according 
to Laemmli (1970). The samples were added to 4SDS-sample buffer (0.4 ml 
a.dest., 1.6 ml 0.5 M Tris pH 6.8, 1.6 ml glycerin, 3.2 ml 10 % SDS, 0.8 ml -
mercaptoethanol, 0.4 ml 0.5 % (w / v) bromphenolblau). Under heat conditions 
(5 min. at 95 °C), the proteins were denatured with SDS (sodium dodecyl 
sulfate). The poly acrylamide gel was composed of 5 % collecting gel (2.9 ml 
a.dest., 0.83 ml acrylamide/bisacrylamide, 1.25 ml 0.5 M Tris pH 6.8, 50 l 
10 % SDS, 25 l 10 % APS, 5 l TEMED) and 7.5 % (4.9 ml a.dest., 2.5 ml 
acrylamide/bisacrylamide, 2.5 ml 1.5 M Tris pH 8.8, 100 l 10 % SDS, 50 l 
10 % APS, 5 l TEMED) separating gel. The buffer was made up as follows: 
0.5 M Tris pH 6.8: 91 g Tris was solved in 400 ml a.dest.. The pH value was 
adjusted with 32 % HCl to 6.8 and the total volume was adjusted with a.dest. to 
500 ml. 1.5 M Tris pH 8.8: 30.3 g Tris was solved in 400 ml a.dest.. The pH 
value was adjusted with 32 % HCl to 8.8 and the total volume was adjusted with 
a.dest. to 500 ml. A molecular mass standard marker (Spectra
™
 Multicolor 
Broad Range Protein Ladder, Fermentas) was run on the gel with the samples to 
separate them according to their apparent molecular mass during their 
movement through the gel in direction of the anode. Gels were run for 90 min at 
120 V. Then the samples were blotted onto a nitrocellulose membrane in a 
Tank-Blot system (BioRad) with 1 blotting buffer (5 g Tris, 72 g glycine, 1 l 
methanol, a.dest. to 5 l) for 90 min at 120 V at 4 °C. With Ponceau S-staining 
solution (Sigma), blots were checked for the successful and equal transfer. The 
membrane was washed with TBS-T buffer (50 ml 10TBS-buffer, 250 l 
Tween 20 (Sigma), a.dest. to 500 ml). The 10TBS-buffer was made from 121 g 
Tris and 400 g sodium chloride. The pH value was adjusted with 32 % HCL to 
7.6 and the total volume was adjusted with a.dest. to 5 l. 
For the specific detection of proteins, the membrane was incubated in 5 % 
skimmed milk (skimmed milk powder solved in TBS-T) with the primary 
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antibodies (table 3-1) overnight. After 3 times washing with TBS-T, the 
corresponding secondary antibodies (solved in 5 % skimmed milk) were added. 
 
Table 3-1 Antibodies for Western blot analysis 
antibodies Description produced in dilution Manufacturers 
anti-rabbit HRP-conjugated goat 1:10000 Sigma-Aldrich 
anti-mouse HRP-conjugated goat 1:10000 Sigma-Aldrich 
anti--tubulin Monoclonal mouse 1:1000 Santa Cruz Biotechnology 
anti-HIF-1 Monoclonal mouse 1:1000 BD Transduction Laboratories 
anti-HIF-2 Polyclonal rabbit 1:1000 Novus Biologicals 
anti-HIF-2 Polyclonal rabbit 1:1000 Thermo Scientific 
anti-ARNT Polyclonal rabbit 1:1000 Cell Signaling 
anti-GFP Polyclonal rabbit 1:200 Clontech 
anti-HA Polyclonal rabbit 1:1000 Sigma-Aldrich 
anti-GAL4 Monoclonal mouse 1:1000 Santa Cruz Biotechnology 
 
The detection was performed using the ECL system (Amersham ECL Advance 
Western-Blotting Detection Kit, GE Healthcare). After 1 h incubation of the 
membrane with respective secondary antibodies directed against the primary 
antibodies, membranes were washed 3 times and then incubated with each 
250 l reagent A and B from the ECL-kits. Luminescent light was collected 
with a Fusion (PEQLAB Biotechnologie) system and documented for further 
evaluation. 
 
Co-Immunoprecipitation 
For the co-immunoprecipitation experiment, GAL4-HIF-2α HA-HIF-1α and 
HA-HIF-2α (Prof. E Metzen, Essen, Germany) were used. Procedures were 
performed at 4 °C. Cells were added to NP40 lysis buffer. Protein concentration 
was measured and 500 µg proteins were transferred into 1.5 ml Eppendorf tube. 
Total volume was adjusted with lysis buffer to 500 µl. Protein was incubated 
with 4 µl agarose conjugated anti-GAL4 antibody (500 µg/0.25 ml, Santa Cruz 
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Biotechnology) and rotated overnight, so that the protein with GAL4-tag was 
immunoprecipitated. Next day, the agarose binding pellet was spun down and 
washed 5 times with each 1 ml NP40 lysis buffer to remove the unbound 
proteins. Finally, the pellet was resuspended with 10 µl 4×SDS, boiled for 5 min 
at 95 °C with vortexing every 30 s to release the agarose and loaded onto the 
Western blot gel. Anti-HA antibodies (Sigma-Aldrich) were used to detect the 
co-immunoprecipitated protein with HA-tag. 
 
Electro-Mobility-Shift-Assay 
Double-stranded asymmetric W18 (AGCTTGCCCTACGTGCTGTCTCAG) 
and palindrome hBnip3 oligonucleotides 
(ACGCGCCGCACGTGCCACACGCAC) including the HRE (bold letters) of 
the erythropoietin gene were annealed and labeled with radioactive
 32
P with T4 
DNA polynucleotide kinase. Nuclear extracts generated by NE-PER Nuclear 
and Cytoplasmic Extraction Kit (Thermo Scientific) were dialyzed with 
4×dialysis buffer (1 mM sodium orthovanadate, 0.5 mM dithiothreitol (DTT), 
20 mM Tris-HCL and 100 mM KCL were dissolved in 1500 ml a.dest., 20 % 
glycerol and 0.5 M EDTA were added. The pH was adjusted to 7.8 with 37 % 
HCL and total volume was made up to 2 l with a.dest.) and subsequently 
incubated with 4×dialysis buffer, 5×binding buffer (25 mM Tris-HCL, 125 mM 
KCL, 5 mM MgCl2, 4.75 mM EDTA, 25 mM DTT, 0.15 % NP40), PolydI-
dC(150 ng/ul), mutant sample (1000 ng/µl), sterile water, competitor (unlabeled 
oligonucleotide) and antibody (in case of supershift) for 5 min at room 
temperature. The 
32
P-labelled oligo probe was added and incubated at room 
temperature for another 20 min. Prerun of the 5 % native polyacrylamide gel 
was done at 300 V and 4 °C for about 30 min and then the samples were loaded 
on the gel. The gel was run in 0.5×Tris-Borate EDTA buffer (5×TBE: 54 g Tris 
base, 27.5 g boric acid and 0.5 M EDTA (pH 8.0) were solved in a.dest. up to 1 l 
with pH 8.0) at 300 V in the cold room (at 4 °C) for about 45 min. The gel was 
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dried in vacuum at 85 °C for 2 h. Finally, the samples were transferred to the 
plastic wrap, which could be exposed and developed under X-ray. 
 
3.3 RNA Methods 
Isolation of RNA from Cells 
Cells were cultured in 6 well plates to a confluence of 50-60 % for respective 
experiments. All experiments were performed in triplicate. To isolate the RNA, 
culture medium was drawn off on ice, 700 µl 4 M GTC (236.4 g guanidium 
thiocyanate, 4.18 ml 3 M NaOAc, pH 5.2, in 500 ml DEPC-H2O (500 µl 
diethylpyrocarbonate (DEPC) in 500 ml a.dest., autoclaved for 40 min) with 
3.75 ml β-mercaptoethanol) was added and the samples were stored at -20 °C 
overnight. At the next day, samples were transferred to 2 ml tubes and 70 µl 
NaAc (16.41 g sodium acetate was solved in 100 ml a.dest., to pH 4.0 adjusted 
with glacial acetic acid) was added. 500 µl phenol (AppliChem) and 350 µl 
phenol-chloroform-isoamyl (AppliChem) were added under the fume hood. 
After vortexing, the samples were milky. After storage on ice for 1 h, samples 
were centrifuged at 13000 rpm for 30 min. The supernatants (only including 
RNA) were transferred to new 1.5 ml tubes. 500 µl isopropanol (CARLO 
ERBR) was added and after vortexing, the samples were stored at -20 °C 
overnight. At next day, samples were centrifuged at 13000 rpm and 4 °C for 
another 20 min. The supernatants were carefully removed under the fume hood. 
The pellets were dried by inverting the tubes on paper towels. Subsequently, 
500 µl GTC and 500 µl isopropanol were added to the samples. After vortex, the 
samples were stored at -20 °C overnight. At the next day, the sapmles were 
centrifuged at 13000 rpm and 4 °C for 30 min. After that, the supernatants were 
carefully removed and samples were dried by inverting the tubes on paper 
towels. 500 µl 75 % ethanol (100 % ethanol diluted in DEPC-H2O) was added to 
the samples and the samples were incubated at room temperature for 30 min. 
After short vortexing, the samples were centrifuged at 13000 rpm and 4 °C for 
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30 min. The supernatants were carefully removed and the pellets were dried at 
room temperature for about 45 min to ensure the complete removal of the 
solvent. From this step stuffed pipette tips had to be used to avoid the 
degradation of mRNA. The samples were dissolved in 10-20 µl DEPC-H2O at 
60 °C and 1 µl samples were used for photometric measurement using the Epoch 
(BioTek) using 260 nm for determination of the RNA concentration and 280 nm 
for determination of the protein contamination. Usually a ratio for 260/280 nm 
of 1.8 was achieved. mRNA samples were stored at -80 °C. 
 
Reverse Transcription 
For reverse transcription (RT) of mRNA into single-stranded complementary 
DNA (cDNA), mRNA was transcribed using oligo-(dT), dNTPs and reverse 
transcriptase (MMLV-RT, Promega). For the RT, DEPC-H2O was added to 1 µg 
mRNA with 2.5 µl oligo-dT to the total volume of 12 µl. Samples were heated 
at 68 °C for 10 min, to denature secondary RNA structures and allow oligo-dT 
to bind to the poly-A tail of the mRNA. After cooling down of the samples on 
ice, 13 µl RT-mix (for each sample, 5 µl 5×RT-buffer, 5 µl dNTP, 0.5 µl 
MMLV-RT and 2.5 µl H2O) was added to each sample. The transcription was 
carried out as shown in table 3-2: 
 
Table 3-2 RT-program 
cycles temperature (°C) time (min) 
1× 45 90 
1× 52 30 
1× 96 15 
 
The cDNAs were shortly stored at 4 °C and long-term at -20 °C. 
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PCR 
With the help of a qualitative PCR (polymerase chain reaction), the quality of 
RT was checked. The GoTaq DNA polymerase was used to amplify the 
investigated gene. Primers were chosen so that they were also suitable for qRT-
PCR (quantitative real time PCR) and approximately 100-150 bp in size PCR-
products were produced. 24.5 µl of mix (5 µl 5×buffer, 2 µl dNTPs, 0.5 µl 
primer s, 0.5 µl primer a, 16.5 µl H2O and 0.05 µl GoTaq polymerase) were 
mixed with 0.5 µl cDNA from the previous RT. The PCRs for β-actin and 
carbonic anhydrase 9 (CA9) were carried out as shown in the following tables 3-
3 and 3-4. 
 
Table 3-3 PCR-program for β-actin in reverse transcription 
cycles temperature (°C) Time 
1× 96 3 min 
25× 96 
60 
72 
1 min 
90 sec 
3 min 
1× 72 10 min 
 
Table 3-4 PCR-program for carbonic anhydrase 9 in reverse transcription 
cycles temperature (°C) Time 
1× 96 3 min 
30× 96 
60 
72 
1 min 
90 sec 
3 min 
1× 72 10 min 
 
The PCR-products were run in agarose gels with 2 % ethidium bromide, which 
intercalates into DNA to make PCR products fluorescent after UV-light 
excitation for photo documentation. β-actin served as a housekeeping gene and 
3. Materials and Methods  20 
 
was unchanged. The annealing temperature was adjusted according to the gene-
specific primers. 
 
Quantitative Real Time-PCR 
For the quantitative analysis of cDNA, the real time PCR was performed using 
the Mesa Green qPCR MasterMix
®
 Plus for SYBR assay (Eurogentec). Gene-
specific primers and β-actin primers were used as in the following table: 
 
Table 3-5 Primers for quantification (Invitrogen) 
gene name sequence 5‟→3‟ 
β-actin hactin 3‟ 
hactin 5‟ 
CAG CGG AAC CGC TCA TTG CCA ATG G 
TCA CCC ACA CTG TGC CCA TCT ACG A 
CA9 hCA9 3‟ 
hCA9 5‟ 
CAG CGA TTT CTT CCA AGC G 
CAC GTG GTT CAC CTC AGC AC 
 
Master mix solution for determination in duplicate was mixed with 25 µl 
2×MasterMix
®
, 22 µl H2O, 1 µl primer 5‟ and 1 µl primer 3‟. 1 µl cDNA was 
added to 49 µl mix. The PCR-programs were shown in the following table 3-6 
and 3-7. 
 
Table 3-6 PCR-program for β-actin in quantitative real time-PCR 
cycles temperature (°C) Time 
1× 95 10 min 
35× 95 
60 
15 sec 
1 min 
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Table 3-7 PCR-program for carbonic anhydrase 9 in quantitative real time-PCR 
cycles temperature (°C) time 
1× 95 10 min 
40× 95 
60 
15 sec 
1 min 
 
The analysis was carried out using delta-delta ct method with the formula:  
2^-ddCT = 2^-((CT-target - CT-endo)-time2 - (CT-target - CT-endo)-time1) 
 
3.4 Molecular-Biological Method 
 
Gateway
®
-Cloning System 
Based on the bacteriophage lambda site-specific recombination system, the 
Gateway Technology facilitates the integration of lambda phage DNA into the 
E. coli chromosome and the switch between the lytic and lysogenic pathways 
(Ptashne, 1992). The lysogenic pathway is catalyzed by the bacteriophage λ 
Integrase (Int) and E. coli Integration Host Factor (IHF) proteins (BP Clonase™ 
II enzyme mix, Invitrogen) while the lytic pathway is catalyzed by the 
bacteriophage λ Int and Excisionase (Xis) proteins, and the E. coli Integration 
Host Factor protein (LR Clonase™ II enzyme mix, Invitrogen; Landy, 1989; 
Ptashne, 1992). As in the following table shown, two recombination reactions 
constitute the basis of the Gateway: BP reaction and LR reaction.  
 
Table 3-8 Recombination reactions of Gateway system 
 name reaction pathway enzymes 
BP attB × attP → attL × attR lysogenic BP Clonase™ 
LR attL × attR → attB × attP lytic LR Clonase™ 
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The BP reaction is carried out with an attB substrate (attB-PCR product or a 
linearized attB expression clone) and an attP substrate (donor vector, in this 
study pDONR/Zeo) to create a gene of interest included attL-entry clone and a 
by-product attR-ccdB. 
 
 
Fig. 3-2: Schema of BP reaction (modified from Invitrogen) 
The key point of the Gateway system is the gene of interest involved entry clone, which can 
be generated form the BP reaction catalyzed by BP Clonase. attB sites are flanked to the gene 
of interest by PCR, so that the gene exchanges the ccdB of the donor vector. 
 
The LR reaction is carried out with an attL substrate (gene of interest included 
attL-entry clone) and an attR substrate (destination vector, in this study pcDNA 
6.2-N-CFP/YFP-DEST) to create an attB-containing expression clone and a by-
product attP-ccdB. 
 
 
Fig. 3-3: Schema of LR reaction (modified from Invitrogen) 
To generate an expression clone with the gene of interest, the attL flanked entry clone reacts 
with the attR flanked destination vector catalyzed with LR Clonase.  
 
BP Reaction 
In this study, N-terminal fused pExp-CFP-HIF-2αΔPASAB and pExp-CFP-HIF-
2αPASBm. were cloned from native HIF-2αΔPASAB and HIF-2αPASBm. 
(Yang et al., 2005) for the FRET study. For this purpose, attB PCR product with 
the gene of interest was firstly generated from the two native plasmids. To 
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design the primers, expression elements like ribosome recognition sequences, 
start codon, stop codons and reading frame were considered (table 3-9).  
 
Table 3-9 Primers involved attB to amplify the N-terminal of gene 
name Sequences 
attB1 GGGGACAAGTTTGTCAAAAAAAGCAGGCTTC 
ATGACAGCTGACAAGGAGAAGAAAAGG 
attB2 ATATATTGGGGACCACTTTGTACAAGAAAGCTGGGTC 
TCAGGTGGCCTGGTCCAG 
 
In tab. 3-9, bold labeled sequences are attB sites. Red labeled sequences are start 
and stop codons. The rest are HIF-2α specific sequences. The PCR reaction was 
carried out with PfuTurbo DNA polymerase (Fermentas) as shown in the 
following tables: 
 
Table 3-10 PCR-program for attB-HIF-2αΔPASAB 
cycles temperature (°C) time 
1× 95 2 min 
30× 95 
57 
72 
30 sec 
30 sec 
2 min 
1× 72 10 min 
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Table 3-11 PCR-program for attB-HIF-2αPASBm. 
cycles temperature (°C) time 
1× 95 2 min 
30× 95 
58 
72 
30 sec 
30 sec 
3 min 
1× 72 10 min 
 
150 ng (1-7 µl) PCR products with the attB sites were mixed with 1 µl 
150 ng/µl donor vector (pDONR/Zeo, see Fig. 3-4) and 8 µl TE buffer pH 8.0. 
2 µl BP Clonase was added to the mix and incubated at room temperature 
overnight. 1 µl Proteinase K was added to each sample and incubated at 37 °C 
for 10 min to terminate the reaction. 
 
pDONR/Zeo
4291 bp
ccdB Cm(R)
Zeo(R )
M13 (-20) forward primer
M13 (-40) forward primer M13 reverse primer
T7 primer
EM7 promoter
T7 promoter
rrnB T1 transcription terminator
rrnB T2 transcription terminator
attP1
attP2
 
Fig. 3-4: Feature map of pDONR/Zeo (modified from Invitrogen) 
Donor vector as pDONR/Zeo is flanked with attP sites. ccdB gene allows negative selection 
in E. coli like TOP10 and DH5α.  Cm (R) (Chloramphenicol resistance gene) is for 
counterselection. Additionally, pDONR/Zeo is kanamycin resistant. 
 
During the BP reaction, the gene of interest in the attB PCR product exchanged 
the ccdB gene of pDONR/Zeo (inhibited to growth in most E. coli because of 
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the interfering with E. coli DNA gyrase (Bernard and Couturier, 1992) by the 
ccdB gene) to form the entry clone (Fig. 3-2), which was kanamycin resistant, 
and a linearized by-product attR-ccdB. After transformation, selection with 
kanamycin plate and isolation of DNA, the entry vector was ready for the further 
LR reaction. 
 
LR Reaction 
150 ng kanamycin resistant entry vector from last step (1-7 µl) was mixed with 
1 µl 150 ng/µl destination vector (pcDNA 6.2-N-CFP-DEST, see Fig. 3-5) and 
8 µl TE buffer pH 8.0. 2 µl LR Clonase was added to the mix and incubated at 
room temperature overnight. 1 µl Proteinase K was added to each sample and 
incubated at 37 °C for 10 min to terminate the reaction. 
 
pcDNA 6.2/N-CFP-DEST
7530 bp
CmR
Blasticidin AmpicillinattR1 site attR2 site
V5
TK pA
TK polyadenylation signal f1 ori
SV40 pA Amp promotor (bla)CFPCMV
SV40ori
EM7
pUC oriccdB
 
Fig. 3-5: Feature map of pcDNA 6.2-N-CFP-DEST (cloned by Dr. Rebecca Konietzky) 
Destination vector as pcDNA 6.2-N-CFP-DEST is flanked with attR sites. ccdB gene allows 
negative selection in E. coli like TOP10 and DH5α.  Cm (R) (Chloramphenicol resistance 
gene) is for counterselection. Additionally, pcDNA 6.2-N-CFP-DEST is ampicillin resistant. 
 
During the LR reaction, the kanamycin resistant entry vector reacted with the 
ampicillin resistant pcDNA 6.2-N-CFP-DEST (ccdB effect) to form expression 
clone pExp-CFP-HIF-2αΔPASAB (ampicillin resistant) and pExp-HIF-
2αPASBm. (ampicillin resistant), and a ccdB involved by-product attP-ccdB 
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(Fig. 3-3). After transformation, selection with ampicillin plate and isolation of 
DNA, the expression vectors pExp-CFP-HIF-2αΔPASAB and pExp-HIF-
2αPASBm. were ready for further use in the FRET microscopic study. 
 
Creating a Deletion by Overlap Extension PCR 
To delete a desired fragment (black fragment in Fig. 3-6) from existing DNA, 
primers a and d are designed including restriction points on their 5‟ sides (or the 
restriction points are involved in the PCR products of step 1 and step 2) for 
further digests. Primers b and c are designed so that their 3‟ ends hybridize to 
template sequence (red fragment of primer b and green fragment of primer c, 
Fig. 3-6) on one side of the deletion, and the 5‟ ends are complementary to 
another side of the deletion (green fragment of primer b and red fragment of 
primer c, Fig. 3-6).  
 
 
Fig. 3-6: Deletion by overlap extension PCR 
The sequence to be deleted is labeled with black lines. The red and green lines indicate the 
template fragments on either side of the deleted sequence. Primers a, b, c and d are needed for 
overlap extension PCR. Specially, the primers b and c are designed such that their 5‟ ends are 
complementary to template sequence on another side of the deletion. 
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In this study, the bHLH was deleted form the pExp-YFP-ARNT. According the 
overlap extension PCR method, primers were designed as in the following table: 
 
Table 3-12 Primers for deletion of bHLH using overlap extension PCR 
name Sequences 
ARNTdbHLH-
BamHI-s (primer a) 
AAGGATCCCTACCGGTGA 
ARNTdbHLH-int-a 
(primer b) 
TGGATGTGTTGCCAGTTCCAAGTCTCTCTTTATC
CGCAGA 
ARNTdbHLH-int-s 
(primer c) 
CTCTGCGGATAAAGAGAGACTTGGAACTGGCAACA
CATCC 
ARNTdbHLH-
Bsu36I-a (primer d) 
TCCTGGAAGACCTCAGGCT 
 
In table 3-12, blue labeled sequences represented the restriction point of primers 
ARNTdbHLH-BamHI-s and ARNTdbHLH-Bsu36I-a, respectively. The green 
labeled sequence of primer ARNTdbHLH-int-a was 5‟ end overhang, which was 
the complementary end, while the red one bound to the template. The red 
labeled sequence of primer ARNTdbHLH-int-s was the 5‟ end overhang, which 
was the complementary end, while the green one bound to the template. Using 
these primers, three steps PCRs (Tab. 3-13 to 3-15) were carried out using 
PfuTrubo DNA Polymerase (Fermentas). 
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Table 3-13 Step 1 of overlap extension PCR-program 
cycles temperature (°C) Time 
1× 95 2 min 
30× 95 
52 
72 
30 sec 
30 sec 
1 min 15 sec 
1× 72 10 min 
 
 
Table 3-14 Step 2 of overlap extension PCR-program 
cycles temperature (°C) Time 
1× 95 2 min 
30× 95 
52 
72 
30 sec 
30 sec 
2 min 
1× 72 10 min 
 
 
Table 3-15 Step 3 of overlap extension PCR-program 
cycles temperature (°C) Time 
1× 95 2 min 
30× 95 
54 
72 
30 sec 
30 sec 
3 min 
1× 72 10 min 
 
The bHLH-deleted PCR product from step 3 was double digested with BamHI 
and Bsu36I (New England BioLabs) and ligated with T4-Ligase (New England 
BioLabs; see next paragraph) into the original YFP expression vector. 
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Cleavage of DNA with Restriction Endonuclease and Ligation of DNA 
Fragments 
Phosphodiester bonds of DNA can be hydrolytically split by over 3000 
restriction endonucleases specifically (Pingoud et al., 2001). The restriction 
endonucleases differ by source organisms, the recognition sequences and 
interfaces. The restriction of DNA was carried out in enzyme-specific buffer 
(NEBuffer 1, 2, 3 and 4, New England BioLabs) at the optimum temperature 
provided by the manufacturer. In case of double restrictions in one reaction, the 
software Double Digest Finder from NEB was applied for testing. For the 
double digest, 1 µg plasmid or PCR product was mixed with 2 µl 10×NEBuffer 
(1, 2, 3 or 4 according to the enzyme characteristics, New England BioLabs), 
2 µl 10×BSA (if necessary, New England BioLabs) and 1 µl enzyme 
respectively. Total volume was adjusted with H2O to 20 µl. The mix was 
incubated at 37 °C for 1-2 h. 
The ligation of the DNA-fragments was carried out with T4-Ligase (New 
England BioLabs). Before the ligation, 50 µl insert PCR product was 
phosphorylated with 1 µl T4 Polynucleotide Kinase (PNK, New England 
BioLabs), 6 µl 10×PNK buffer and 3 µl H2O to total volume of 60 µl for 30 min 
incubation at 37 °C. The T4 Polynucleotide Kinase was inactivated at 60 °C for 
20 min. Simultaneously, 50 µl vector needed to be dephosphorylated with 1 µl 
Antarctic-Phosphatase (New England BioLabs), 6 µl 10×Antarctic-buffer and 
3 µl H2O to total volume of 60 µl for 15 min incubation at 37 °C. The Antarctic-
Phosphatase was inactivated at 65 °C for 5 min. Finally, 25 ng dephosphorylated 
vector was mixed with 5 times phosphorylated PCR insert, 1 µl T4 Ligase, 1 µl 
10×ligase buffer to a total volume of 10 µl for 9 h incubation at 16 °C. 1 µl of 
the ligated mix was prepared for further transformation. 
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Transformation 
Transformation into bacteria was performed according to the heat shock method 
described by Sambrook et al. (1989). E. coli of Top10 (characteristic: F
-
 mcrA Δ 
(mrr-hsdRMS-mcrBC) Φ 80lac ZΔM15 ΔlacX74 recA1 araΔ139 Δ (ara-
Leu)7697 galU galK rpsL (Str
R
) endA1 nupG) from Invitrogen was applied. 
0.1 µg plasmid was mixed with Top10 E. coli and incubated for 30 min on ice. 
Heat shock was carried out at 42 °C for 30 sec. 250 µl SOC (Invitrogen) was 
given to the mix and shook for 1 h at 37 °C. After that, 50 µl mix was pipetted to 
ampicillin (Calbiochem) or kanamycin (Calbiochem) plate (3.5 g Difco 
Antibiotic Medium 3 (BD Transduction Laboratories), 3 g Select Agar (Life 
Technologies) were solved with a.dest. to total volume of 200 ml and 
autoclaved. After cooling down, the gel was treated with 200 µl 10 mg/ml 
antibiotic and allocated to 94 mm dishes with each 20 ml volume) and incubated 
at 37 °C overnight. 
 
Isolation of Plasmid 
The transformed bacteria were incubated in LB medium (10 g trypton, 5 g 
sodium chloride, 5 g yeast extract (ICN Biomedicals) solved in a.dest. to a total 
volume of 1 l) at 37 °C overnight. The plasmid was isolated using GeneJet 
Plasmid Miniprep Kit (Fermentas) and PureYield™ Plasmid Midiprep System 
(Promega) according the guideline of manufacturers. 
 
Determination of Concentration of the Isolated Plasmids 
The yield and purity of the plasmid DNA was determined photometrically at 
wavelengths of 260 and 280 nm using Epoch Take 3 (BioTek). 
 
Sequencing 
The sequencing was carried out by Microsynth (Switzerland). The primers for 
the sequencing are shown in table 3-16. 
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Table 3-16 Primers for sequencing 
name of the vector sequences 
pExp-YFP-ARNTΔbHLH TACCAGCAGAACACCCCCAT 
pENT-HIF-2αPASBm. TAACGCTAGCATGGATGT 
pENT-HIF-2αΔPASAB TAACGCTAGCATGGATGT 
 
Horizontal Gel Electrophoresis of DNA 
The horizontal agarose gel electrophoresis firstly described by Sambrook et al. 
(1989) was used for separation of DNA. Due to the negative charge of 
phosphate residues, DNA migrated in the electric field to the anode. The linear 
DNA fragments were separated dependent on their molecular weight. 0.2-2 % 
(w/v) agarose in Tris acetate-EDTA (TAE)-buffer (50×TAE: 242 g Tris, 57.1 ml 
glacial acetic acid and 100 ml 0.5 M EDTA pH 8.0 were adjusted with a.dest. to 
1 l total volume) was boiled. The warm solution was treated with 50 µg/ml 
ethidium bromide solution to reach a concentration of 0.07 % and poured into a 
gel chamber. Due to its planar properties, ethidium bromide was intercalated 
into the heteroaromatic rings of the DNA helix. After polymerization, the 
sample pockets were loaded with size marker (1 kb ladder and 100 bp ladder, 
New England BioLabs and Invitrogen) and samples. The buffer was filled up to 
the upper edge of the gels in the chamber and treated with an electric current of 
6.25 V/cm. After 2 min pre-running, the chamber was filled with sample buffer 
to flood the gel. The electrophoresis was carried out at 5 V/cm for 40-60 min. 
The detection of the DNA was carried out under UV light at an excitation 
wavelength of 304 nm for ethidium bromide fluorescence. 
 
Purification of DNA Fragments from Agarose Gel 
The expected DNA bands with the corresponding sizes were excised from the 
gel using a scalpel and isolated with QIAquick Gel Extraction Kit (Qiagen) 
according to the guideline of manufacturer. 
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3.5 Cytological Methods 
 
Hypoxia Experiment 
Since the most HIF target genes like CA9, VEGF and EPO are inducible in 
hypoxia, cell culture experiments were carried out under hypoxia. For normoxic 
controls cells were kept in 21 % O2, 5 % CO2, 37 °C and 90 % humidity. 
Culturing the cells in hypoxia was carried out in a hypoxic incubator, equipped 
with BBL GasPak glasses using BBL™ GasPak™ Plus Anaerobic System 
Envelopes with Palladium Catalyst (BD BBL). In this study, all the hypoxia 
experiments were carried out in 1 % hypoxia (1 % O2, 5 % CO2, 74 % N2, and 
90 % humidity at 37 °C) for 6 h. 
 
Transient Transfection 
The cells were seeded for transfection with a confluence of 50-80 %. Following 
the guideline of manufacturer, 0.25 µg, 1 µg, 1 µg and 5 µg plasmids and 3 
times the amount of GeneJuice
®
 Transfection Reagent (Novagen) were used in 
24 well plates (for luciferase reporter gene), 6 well plates (for Western blot), 
35 mm dishes (for FRET) and 60 mm dishes (for EMSA and co-
immunoprecipitation), respectively. Serum-free medium (20 to 300 µl) was 
mixed with GeneJuice for 5 min at room temperature. Plasmids were added to 
this mix and incubated for another 15 min at room temperature. Lastly, the 
whole mix was directly added to the cells for 24 h incubation and further 
analysis. 
 
Reporter Gene Assay 
For the analysis of HIF activity in U2OS, cells were transfected with a reporter 
gene (pH3SVL, Fig. 3-7) for the respective experimental conditions (normoxia 
and hypoxia). The plasmid pH3SVL was provided by Prof. R. Wenger, Zurich 
(Rolfs et al., 1997). The luciferase reporter gene was composed of an SV40 
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promoter and three HRE (hypoxia-responsive elements) from the 5 'enhancer of 
the transferrin. The HRE of the transferrin consists of two HBSs (HIF binding 
sites). During the experiment, luciferase was expressed under control of the 
HRE and depending on the degree of HIF activation (Fig. 3-7). Using the firefly 
luciferase assay kit (Biotium), luciferase activity was determined in a 
luminometer according to the guideline of manufacturer. HIF-activity was 
expressed relative to total cellular protein concentration. All reporter gene assay 
experiment was carried as triplicates. 
 
 
Fig. 3-7: Structure of the pH3SVL 
The reporter gene plasmid pH3SVL expressed luciferase under the control of SV40 promoter 
and three HREs transferrin genes. 
 
 
Fig. 3-8: Reaction of the luciferase reporter gene (modified form Yikrazuul) 
The luciferin substrate (Biotium) was oxidized by luciferase expressed form pH3SVL to oxy-
luciferin releasing with a photon of light as oxyluciferin returned from its exited state to 
ground state. 
 
luciferin 
oxy-luciferin 
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3.6 Confocal laser Microscopy 
 
Analysis of Protein-Protein Interactions by FRET 
To study protein-protein interactions in living cells, the modern confocal laser 
microscopy method FRET (fluorescence resonance energy transfer) was applied. 
This technique depends on the energy transfer between two chromophores, 
which was firstly described by Theodor Förster in 1926. Usually for FRET, the 
utilized choromophore pair is CFP (cyan fluorescent protein) and YFP (yellow 
fluorescent protein). Due to the overlap of the emission spectrum of the CFP and 
the excitation spectrum of the YFP (Fig. 3-9), energy can be transferred from the 
excited donor fluorophore (CFP) to the acceptor fluorophore (YFP) through non 
radiative dipole-dipole coupling, once the donor fluorophore gets close to the 
acceptor fluorophore. The degree of transferred energy, which is called FRET 
efficiency, is dependent on the intermolecular protein-protein distance R 
between the two fluorophores (Fig. 3-10 A). The constant R0 is named Förster 
distance, which describes the distance of the fluorophore pair of donor and 
acceptor, i.e. the distance at which the energy transfer efficiency is 50 % (Fig. 3-
10 B). R0 is flurophore specific and for CFP/YFP pair 4.92 nm (Patterson et al., 
2000). Additionally, R0 was dependent on the refractive index of the donor 
quantum efficiency, the spectral overlap integral and the relative orientation of 
the transition dipole moments of donor and acceptor (Lakowicz, 2006) 
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Fig. 3-9: Excitation and emission spectra of CFP and YFP (modified form Fluorescence 
SpectraViewer of Invitrogen) 
The overlapped spectra of emission (CFP) and excitation (YFP) ensure the FRET energy 
transfer from CFP to YFP. 
 
 
 
 
 
 
 
 
Fig. 3-10: Schema of FRET formula 
(A) The distance between two proteins was calculated with the formula, composed of FRET 
efficiency E and Förster distance R0. (B) 4.92 nm was the Förster distance R0 of CFP and 
YFP, calculated when the FRET efficiency is 50 %.  
 
To apply this method to investigate the protein-protein interaction, all the 
candidates were labeled with CFP or YFP (Tab. 3-17). Without energy transfer, 
A B 
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the donor (CFP) is excited with the corresponding absorption wavelength 
(444 nm) and there is a CFP specific emission wavelength at 475 nm (Fig. 3-11). 
If the distance between the two fusion proteins is less than 10 nm, an energy 
transfer from CFP to YFP takes place and the emission of CFP is reduced 
(quenched), since part of the energy is transferred to the acceptor (YFP) to 
initiate a YFP specific emission wavelength of 532 nm (Fig. 3-11). 
 
 
Fig. 3-11: Physical principle of the energy transfer during FRET (modified from S. 
Jähnichen) 
CFP flurophore alone was excited by 444 nm laser and emitted by 475 nm. Physically, the 
electron was excited from S0 level to S1 level and fell back from S1 to S0 with an emission of 
475 nm. In case the YFP flurophore got close to CFP, the emitted energy of CFP was 
transferred to YFP non-radiatively so that the YFP was excited and emitted at 532 nm 
wavelength.  
 
During the experiment, several cells had to be analyzed to get the FRET 
efficiency, which is recorded against the acceptor/donor (YFP/CFP) ratio. 
Furthermore, the examination of the final plateau FRET efficiency was 
calculated using an exponential function (Fig. 4-1). If the plateau of the FRET 
efficiency was reached, the acceptor/donor ratio did no longer influence the 
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FRET efficiency. Using the formula (Fig. 3-10 A), the distance between the two 
partners can be calculated (Wotzlaw et al., 2007). 
 
Table 3-17 CFP or YFP labeled vectors 
N-terminal  Cards 
pcDNA 6.2-N-CFP-DEST 
pcDNA 6.2/N-CFP-DEST
7530 bp
CmR
Blasticidin AmpicillinattR1 site attR2 site
V5
TK pA
TK polyadenylation signal f1 ori
SV40 pA Amp promotor (bla)CFPCMV
SV40ori
EM7
pUC oriccdB
 
pcDNA 6.2-N-YFP-DEST 
pcDNA 6.2/N-YFP-DEST
7530 bp
CmR
Blasticidin AmpicillinattR1 site attR2 site
V5
TK pA
TK polyadenylation signal f1 ori
SV40 pA Amp promotor (bla)CMV
SV40ori
EM7
pUC oriYFP ccdB
 
pExp-CFP-HIF-1α  
pExp-CFP-hHIF1a
8353 bp
Ampicillin
Blasticidin
attB1
attB2
CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5 HIF1a
inPrimer aStart
inPrimer aEnd
bHLH?
inPrimer sEnd
inPrimer sStart
Primer a HIF1a-Stop-a
HIF1a-Stop-s
pDONOR223-HIF1aFL-5158bp-s
SV40ori
CMV
EM7
pUC ori
 
pExp-CFP-HIF-1αΔbHLH 
pExp-CFP-hHIF1a de lta bHLH
8191 bp
Ampicillin
Blasticidin
attB1 attB2
CFPAmp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
HIF1a-Stop-a
HIF1a-Stop-s
pDONOR223-HIF1aFL-5158bp-s
HIF-1a delta bHLHSV40ori
CMV
EM7
pUC ori
 
pExp-CFP-HIF-2α 
pExp-CFP-hHIF2a
8524 bp
Ampicillin
Blasticidin
attB1 attB2
CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylation signal
TK pA
V5 HIF2a+STOP
SV40ori
CMV
EM7
pUC ori
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pExp-CFP-HIF-2αΔbHLH 
pExp-CFP-hHIF-2adelta bHLH
8362 bp
Ampicillin
Blasticidin
attB1 attB2
CFPAmp promotor (bla)
SV40 pA
f1 ori
TK polyadenylation signal
TK pA
V5
HIF2a-deltabHLH+STOP
SV40ori
CMV
EM7
pUC ori
 
pExp-YFP-ARNT  
pExp-YFP-hARNT
8247 bp
Ampicillin
Blast icidin
attB1
attB2
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
Koz ak consensus sequence
seq compl okay
seq direct okay
Primer 4for
Primer 3for
Primer 2for
Primer 1for
Primer 1rev
Primer 2rev
Primer 3rev
Primer 4rev
EGFP-C SeqPrimer
SV40ori
CMV
EM7
pUC ori
YFP
hARN T
 
pExp-YFP-ARNTΔbHLH 
pExp-YFP-hARNT delta bHLH
8085 bp
Ampicillin
Blasticidin
attB1
attB2
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
Kozak consensus sequence
seq compl okay
seq direct okay
Primer 4for
Primer 3for
Primer 2for
Primer 1for
Primer 1rev
Primer 2rev
Primer 3rev
Primer 4rev
EGFP-C SeqPrimer
SV40ori
CMV
EM7
pUC ori
YFP
hARN T
 
pExp-CFP-HIF-2αΔPASAB 
pExp-CFP-hHIF2adelta PASAB
7741 bp
Ampicillin
Blast icidin
attB1 attB2CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
HIF2adelta PASAB
SV40ori
CMV
EM7
pUC ori
 
pExp-CFP-HIF-2αPASBm. 
pExp-CFP-hHIF2aPASBm.
8524 bp
Ampicillin
Blasticidin
attB1 attB2
CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylation signal
TK pA
V5 HIF2aPASBm.
SV40ori
CMV
EM7
pUC ori
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Equipment for FRET Study 
For the FRET study, an inverted microscope (Axiovert 200M, Carl Zeiss 
MicroImaging GmbH, Germany) with a Nipkow Disc System (QLC100, 
Visitech International Ltd., USA) was applied. Two diode-pumped solid-state 
lasers (444 nm and 532 nm, Laser Crystal, USA) were used for specific 
excitation of fluorophores CFP and YFP. The laser light was coupled via an 
optical fiber cable into the system and focused on the sample chamber. Lasers 
came on the Nipkow Disc and a Multipec Microimager Dual View (Optical 
Insights, USA) to the CCD camera (Orca ERG, Hamamatsu, Japan). The 
Microimager Dual View served as a detection of two emission images (CFP and 
YFP channel) during the measurements. A special cell observation chamber 
(Luigs and Neumann GmbH, Germany) was used to keep the temperature 
constant. The gas concentrations were adjusted through gas mixer (MKS 
Instruments) to reach an expected gas concentration for normoxia or hypoxia. 
 
 
Fig. 3-12: Components of the microscopic system for FRET study 
Two diode-pumped solid-state lasers with 444 nm and 532 nm lasers were produced in laser 
box, which was coupled with optical fiber cable into the microscope. Gas concentration was 
controlled by gas mixer and sent to the chamber, in which the FRET was studied in living 
cells. 
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Software for FRET Study 
The software for FRET study called Anufis was programed by Dr. A. Bernadini 
and Dr. C. Wotzlaw (2009), updated by Dr. A. Bernadini using Javascript.  
 
3.7 Laboratory Equipment 
 
Table 3-18 Laboratory equipment and manufacturers 
equipment Manufacturers 
autoclave H+P Labortechnik GmbH 
analytical balance, Pioneer OHAUS 
cool centrifuge, 5414R Eppendorf 
cool centrifuge, Biofuge fresco, Labofuge 400 R Heraeus Instruments 
electrophoresis system BioRad 
Fusion system PEQLAB Biotechnologie 
gel documentation for gel cutting LTF Labortechnik 
gel documentation for imaging UVP 
heat block: HLC TM 130-6, HLC HTM 130 Oehmen 
hypoxia incubator, HERA cell 240 Heraeus Instruments 
ice machine AF 10 Scotsman 
incubator, Hera cell Heraeus Instruments 
Invivo2 400, Hypoxia Workstation Russkin/Baker   
light microscope, CK40 Olympus 
luminometer, TD 20/20 Turner Instruments 
PCR-machine: Tpersonal, Tprofessional Biometra 
PCR-machine: Mastercycler personal, Mastercycler Eppendorf 
pH-meter Precisa 
photometer, Epoch BioTek 
photo print for gel documentation MITSUBISHI 
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pipetboy Hirschmann Laborgeräte 
shaker for 37 °C incubation Edmund Bühler 
shaker for Western blot Oehmen 
sterile bench, Hera safe Heraeus Instruments 
table centrifuge, 5415D Eppendorf 
vortexer, Vortex-Genie 2 Scientific Industries 
water bath, GFL Oehmen 
Western blot, Mini Protean 3 Bio-Rad 
water distillation system Köttermann 
Real-Time PCR detection system  Bio-Rad 
 
3.8 Consumables and Chemicals 
 
Table 3-19 Consumables and manufactures 
Name Manufacturers 
culture flasks Greiner 
plastic consumables Sarstedt, Eppendorf, Greiner 
dishes for microscopy Willcowells, Amsterdam 
consumables for Western blot Whatmann 
 
The chemicals were purchased from Sigma-Aldrich, Merck, Fluka, Roth and 
Riedel-de Haën. 
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4. Results 
 
4.1 FRET Study 
FRET was applied for investigation of protein-protein interactions in U2OS 
cells. The FRET efficiency was recorded by Anufis version 1.20, 1.21 and 1.22. 
Data were analyzed in SigmaPlot 11.0 with nonlinear regression „Exponential 
rise to Maximum‟.  
As a negative control, random FRET efficiency was measured after transfection 
of empty CFP and YFP (pcDNA 6.2-N-CFP-DEST and pcDNA 6.2-N-YFP-
DEST) vectors. The low resulting 4.84 % plateau FRET efficiency indicated no 
significant FRET and distance > 10 nm between the fluophores was calculated 
according to the Förster formula (Fig. 3-10 A). Therefore, in case of in U2OS 
cells, positive FRET should be over 5 % FRET efficiency. 
 
 
 
Fig. 4-1: Random FRET measured after CFP/YFP as negative control 
Several cells had to be analyzed to get the plateau FRET efficiency, which is recorded against 
the acceptor/donor (YFP/CFP) ratio. After reaching the plateau FRET, the acceptor/donor 
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ratio does no longer influence FRET. In this case, 4.84 % FRET, representing a distance of 
more than 10 nm, was calculated. 
 
The Role of the bHLH Domain in Heterodimerization 
HIF-α/ARNT complexes have been described as the primary complexes in 
hypoxia which subsequent bind to DNA and regulate HIF-target genes (Wang et 
al., 1995). To detect potential differences between the assembly of the two 
heterocomplexes of HIF-1α or HIF-2α with ARNT, FRET was measured and 
distances of 6.0 nm between HIF-1α/ARNT (Fig. 4-2 A, solid curve) and 6.4 nm 
for HIF-2α/ARNT (Fig. 4-2 B, solid curve) were obtained indicating differences 
in the formation of these two highly similar complexes. To determine the 
contribution of the bHLH for heterodimerization, bHLH-deleted HIF fusion 
proteins (Fig. 2-4, middle section) were used. Interestingly, a distance of 6.4 nm 
was found for both HIF-1αΔbHLH/ARNTΔbHLH (Fig. 4-2 A, dashed curve) 
and HIF-2αΔbHLH/ARNTΔbHLH (Fig. 4-2 B, dashed curve) complexes. 
Compared with the wild type heterodimers, conclusion was made that bHLH 
domain is obviously not required for heterodimerization. 
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Fig. 4-2: bHLH study in heterodimerizatioin 
All measurements were performed under normoxic condition. U2OS cells were transiently co-
transfected with (A) HIF-1α/ARNT, HIF-1αΔbHLH/ARNTΔbHLH respectively and (B) HIF-
2α/ARNT, HIF-2αΔbHLH/ARNTΔbHLH respectively. The dotted curves represent the 
random FRET measured after empty CFP and YFP. 
 
Study of bHLH in Homodimerization 
Among the bHLH-PAS proteins, homodimers have been recognized in several 
studies (Godlewski et al., 2006, Dioum et al., 2002 and Jones, 2004), and in the 
case of HIF proteins, homodimerization of ARNT was firstly described in 1995 
(Sogawa et al., 1995). In this study, we observed the formation of homodimers 
of wildtype HIF-2α (Fig. 4-3 B, solid curve) with a distance of 6.1 nm between 
the subunits but also with HIF-2αΔbHLH (Fig. 4-3 B, dashed curve) with 
distance of 5.9 nm indicating that the bHLH domain is not required for HIF-2α 
homodimerization. Unexpectedly, neither the full-length nor the bHLH-deleted 
HIF-1α could form homodimers (Fig. 4-3 A, black and white dots under the 
random curve, distance > 10 nm), regardless of its high structural similarity 
compared with its isoform HIF-2α. 
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Fig. 4-3: Homodimerization of HIFα-units 
All measurements were performed under normoxic condition. U2OS cells were transiently co-
transfected with (A) HIF-1α/HIF-1α, HIF-1αΔbHLH/HIF-1αΔbHLH respectively and (B) 
HIF-2α/HIF-2α, HIF-2αΔbHLH/HIF-2αΔbHLH respectively. The dotted curves represented 
the random FRET measured after empty CFP and YFP. 
 
Homodimerization of HIF-1α and HIF-2α 
Interestingly, positive FRET with distances of 5.8 nm and 6.1 nm was observed 
on homodimer formation of the two isoforms HIF-1α/HIF-2α and HIF-
1αΔbHLH/HIF-2αΔbHLH, respectively, which was not significantly influenced 
by the absence of bHLH (fig 4-4 B, solid and long dash curves). 
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Fig. 4-4: Homodimer of HIF-1α/HIF-2α 
Both measurements were performed under normoxic condition. U2OS cells were transiently 
co-transfected with HIF-1α/HIF-2α and HIF-1αΔbHLH/HIF-2αΔbHLH, respectively. The 
dotted curves represented the random FRET measured after empty CFP and YFP transfection. 
 
The Role of the PAS Domain in Heterodimerization 
To investigate the function of PAS during heterodimerization, a triple-point-
mutation of PAS B-domain with minimal changes in the β-sheet backbone 
(Yang et al., 2005) and a PAS AB-domain deletion of HIF-2α (Fig. 2-4, lower 
section) were generated. The PAS domain was proposed to be required for 
heterodimerization of HIF-2α/ARNT using its β-sheet interface (Card et al., 
2005). Herein the FRET analysis supported this hypothesis: neither the PAS B-
triple-point-mutant, nor the PAS AB-deleted HIF-2α was able to heterodimerize 
with wildtype ARNT in normoxia (Fig. 4-5 A, black and white triangles were 
below random FRET). Furthermore, the PAS B-triple-point-mutant HIF-2α 
could not form a heterocomplex with wildtype ARNT even in hypoxia with 1 % 
O2 (Fig. 4-5 B, black dots).  
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Fig. 4-5: PAS domain in heterodimerization 
(A) Both measurements were performed under normoxic conditions. U2OS cells were 
transiently co-transfected with HIF-2αΔPASAB/ARNT and HIF-2αPASBm./ARNT, 
respectively. (B) After the co-transfection of HIF-2αΔPASAB/ARNT, FRET was determined 
under 1 % hypoxia. The dotted curves represented the random FRET measured after empty 
CFP and YFP. 
 
The Role of PAS in Homodimerization 
Moreover, no homodimerization was observed during the analysis of HIF-
2αΔPASAB/HIF-2α and HIF-2αΔPASAB/HIF-1α (Fig. 4-6, black square and 
white triangle). These results support the notion that the B-domain of PAS is 
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essential for hetero- but also homodimerization via the exposed face of the β-
sheet on the HIF-2α subunits. 
 
 
 
Fig. 4-6: The role of PAS in homodimerization 
Both measurements were performed under normoxic condition. U2OS cells were transiently 
co-transfected with HIF-2αΔPASAB/HIF-2α and HIF-2αΔPASAB/HIF-1α, respectively. The 
dotted curves represented the random FRET measured after empty CFP and YFP. 
 
4.2 Co-Immunoprecipitation 
To confirm the assembly of homodimers of HIF-2α/HIF-2α (Fig. 4-3 B) and 
HIF-1α/HIF-2α (Fig. 4-4), co-immunoprecipitation was carried out. As the bait 
protein, HIF-2α was labeled with GAL4-tag for immunoprecipitation. As the 
prey proteins, HIF-2α and HIF-1α were tagged with HA for co-
immunoprecipitation and further Western blot detection. As shown in Fig. 4-7, 
GAL4-HIF-2α was able to efficiently co-immunoprecipitate both HA-HIF-2α, 
and HA-HIF-1α, indicating the assembly of HIF homodimers, corresponding 
well with the FRET data. 
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Fig. 4-7: Co-immunoprecipitation for HIF-2α/HIF-2α and HIF-2α/HIF-1α 
For the co-immunoprecipitation, GAL4-HIF-2α was selected as precipitation protein, which 
efficiently coimmunoprecipitated the HA tagged HIF-2α and HIF-1α. Herein, 10 % input of 
the whole cell lysis protein. Single transfection of GAL4-HIF-2α served here as a negative 
control. 
 
4.3 Electro-Mobility-Shift-Assay 
To study potential DNA binding of HIF homo- or heterocomplexes, Electro-
Mobility-Shift-Assays (EMSAs) were performed using the 
32
P labeled W18 
oligo (AGCTTGCCCTACGTGCTGTCTCAG) of the human erythropoietin 
gene enhancer containing the classical HIF binding site (HBS) TACGTG. As 
positive and negative controls, wild type and dKO U2OS (double knockdown of 
endogenous HIF-1α and ARNT, detail see results 4.4) were incubated both in 
normoxia and 1 % hypoxia for 6 h. As shown in Fig. 4-8, the typical hypoxia 
induced shifted complex was observed in hypoxia (lane 2) whereas dKO did not 
show the HIF-complex, neither in normoxia nor in hypoxia (lanes 3 vs 4). 
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Fig. 4-8: Positive and negative controls for EMSA experiments 
EMSA was carried out with oligo W18. TF, CE, SS and HX represent transfections (TF), cell 
extracts (CE), supershifts (SS) and hypoxia (HX) respectively. The mock was treated without 
any transfection. 
 
Study of the bHLH Domain in DNA Binding 
CFP or YFP labeled proteins were transfected in wt. U2OS for the following 
EMSA experiments, so that they could be distinguished from endogenous HIF 
complexes (without CFP and YFP) through their sizes. To identify the function 
of the bHLH during the DNA-binding, HIF-1α/ARNT and HIF-
1αΔbHLH/ARNTΔbHLH were co-transfected into cells, respectively. As shown 
in Fig. 4-9, the overexpression of HIF-1α/ARNT allowed DNA bound 
complexes both in normoxia and hypoxia (lanes 5 and 6), which were 
supershifted with anti-HIF-1α (H1, lane 7) and anti-ARNT (A, lane 8) 
antibodies, but not with a generic IgG (IgG, lane 9) antibody. On the contrary, 
no clear DNA-bound complex was observed after HIF-
1αΔbHLH/ARNTΔbHLH co-transfection (lanes 10 and 11), due to the lack of 
the bHLH domain required for DNA binding. A slight trace in lane 11, which 
ran a little faster than complexes formed from exogenous overexpressed HIFs 
(lane 6 vs. lane 11), was the endogenous DNA-bound HIF-1α/ARNT 
heterocomplex. 
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Fig. 4-9: The role of the bHLH domain for DNA binding 
EMSA was carried out with oligo W18. TF, CE, SS and HX represented transfections (TF), 
cell extracts (CE), supershifts (SS) and hypoxia (HX) respectively. The supershifts were 
performed with anti-HIF-1α (H1), anit-ARNT (A) and anti-IgG (IgG) antibodies. 
 
DNA-Binding Study for Homodimer HIF-2α/HIF-2α 
To study the DNA-binding of the homodimer HIF-2α/HIF-2α, both the 
asymmetric W18 oligo and the palindromic HBS within the Bnip3 promoter 
(ACGCGCCGCACGTGCCACACGCAC) flanked by accessory E-box-like 
elements E1 and E2 (Hu et al., 2011) were used. As shown in Fig. 4-10, the 
exogenous overexpressed HIF-1α/ARNT was used as positive control 
complexes, which were shifted (lane 12) and supershifted with anti- HIF-1α (H1, 
lane 13). The HIF-1αΔbHLH/ARNTΔbHLH co-transfection served here as 
negative control (lane 14, 15, 27 and 28). Although the HIF-2α formed 
homodimers (Fig. 4-3 and Fig. 4-7), this homodimer does not seem to bind to 
the asymmetric W18 HRE probe: Only endogenous HIF-1 complexes were 
observed under hypoxic conditions (lanes 17-21) which were supershifted with 
anti-HIF-1α (H1, lane 18) and anti-ARNT (A, lane 19) antibodies but not anti-
HIF-2α (H2, lanes 20 and 21) antibodies.  
Furthermore, no evidence of HIF-2α homodimer binding to DNA was found 
using the symmetric Bnip3 palindromic HBS probe: Only endogenous HIF-1 
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complexes were observed under hypoxic conditions (lanes 23-26) which were 
supershifted with anti-HIF-1α (H1, lane 26) and anti-ARNT (A, lane 25) 
antibodies but not anti-HIF-2α (H2, lane 24) antibodies. Herein, only faint DNA-
bound complexes unrecognized by anti HIF-1α or anti ARNT antibodies were 
observed (lanes 21, 22, 28 and 29, red arrows), which might contain low affinity 
HIF-2α constituents. It is manifest that the HIF-1α heterodimer, but not the 
HIF-2α containing dimers, remain the predominant species bound to both 
asymmetric W18 and symmetric Bnip3 motif. In other words, HIF-2α preferably 
forms DNA-unbound homodimer, rather than to heterodimerize with 
endogenous ARNT. 
 
 
 
 
 
 
 
 
 
Fig. 4-10: DNA-binding study for homodimer of HIF-2α/HIF-2α 
EMSA was carried out with oligo W18 and Bnip3. Transfections (TF), cell extracts (CE), 
supershifts (SS) and hypoxia (HX) respectively. The supershifts were performed with anti-
HIF-1α (H1), anti-HIF-2α (H2) and anit-ARNT (A) antibodies. 
 
DNA-Binding Study for Homodimer HIF-1α/HIF-2α 
As shown in Fig. 4-11, only very weak complexes, supershifted with anti-HIF-
1α (H1, lane 31) and anti-ARNT (A, lane 32) antibodies but not anti-HIF-2α (H2, 
lane 33) antibodies, were observed in the HIF-1α/HIF-2α homodimer test, 
indicating the endogenous HIF-1α/ARNT heterocomplex. However, compared 
e.g. Fig. 4-10 (lanes 17-21), these HIF-1α/ARNT complexes were apparently 
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weaker, indicating that HIF-2α overexpression inhibited HIF-1α to 
heterodimerize with ARNT by forming a DNA unbound complex HIF-1α/HIF-
2α. 
 
 
 
 
 
 
 
 
 
Fig. 4-11: DNA-binding study for homodimer HIF-1α/HIF-2α 
EMSA was carried out with oligo W18 and Bnip3. Transfections (TF), cell extracts (CE), 
supershifts (SS) and hypoxia (HX) respectively. The supershifts were performed with anti-
HIF-1α (H1), anti-HIF-2α (H2), anit-ARNT (A) and anti-IgG (IgG). 
 
The Role of the PAS Domain for DNA Binding 
To study the role of the PAS domain the HIF-2α-PAS B-triple-point-mutant 
(HIF-2αPASBm.) was used. Neither under normoxia (Fig. 4-12, lanes 35 to 37) 
nor under hypoxia (Fig. 4-12, lanes 38 to 40), exogenous cotransfection of HIF-
2αPASBm./ARNT led to the formation of exogenous DNA bound complexes, 
whereas only endogenous HIF-1 complexes (endogenous HIF-1α with 
endogenous/exogenous ARNT) were observed in hypoxic conditions (Fig. 4-12, 
lanes 38-40). 
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Fig. 4-12: PAS study in DNA binding 
EMSA was carried out with oligo W18 and Bnip3. TF, CE, SS and HX represented 
transfections, cell extracts, supershifts and hypoxia respectively. The supershifts were 
performed with anti-HIF-2α (H2) and anit-ARNT (A). 
 
4.4 Luciferase Reporter Gene Assay and Western Blot 
Using the pH3SVL plasmid in which 3 HRE elements control luciferase reporter 
gene expression, the transcriptional activity of HIF assemblies which included 
the classic heterocomplexes of HIF-α/ARNT and newly identified 
homocomlexes of HIF-α/HIF-α was studied. The U2OS cells belong to the 
common somatic cells, indicating the absence of endogenous HIF-2α (Wiesener 
et al., 2003), however they contain endogenous HIF-1α and ARNT. To avoid 
interference by endogenous HIF complexes, endogenous HIF-1α and ARNT 
were knocked down with sh-HIF-1α and sh-ARNT in U2OS (dKO U2OS were 
generated from Dr. U Brockmeier, Essen, Germany). The knockdown efficiency 
(over 80 %) was confirmed and assessed by Western blot analysis (Fig. 4-13 B): 
Little HIF-2α and only residual HIF-1α and ARNT were observed both in 
normoxia and in hypoxia compared with wild type U2OS. Reasonably, the 
transcriptional activity of the dKO U2OS ceased substantially compared with 
the wild type U2OS both in normoxia and in hypoxia, with the „clean 
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background‟ (Fig 4-13 A). These dKO U2OS cells were applied for the reporter 
gene assay. 
 
 
 
 
 
 
 
 
 
 
Fig. 4-13: Double knockdown of endogenous HIF-1α and ARNT in U2OS 
(A) To investigate the transcriptional activity, a luciferase reporter gene assay was carried out 
in dKO U2OS cells, which were transiently transfected with pH3SVL plasmid reporter gene 
and incubated under normoxic or hypoxic (1 % O2) conditions for 6 h. The values represent 
the average luciferase activity of three replicates with the bars indicating standard error. (B) 
The Western blot provided rough expression levels. 
 
Reporter Gene Assay after Single Transfection 
For single transfection, empty CFP and YFP served as negative controls. HIF-
1α, HIF-1αΔbHLH, HIF-2α, HIF-2α and HIF-2αΔbHLH were single-transfected 
in dKO U2OS cells. With the absence of endogenous ARNT, all of the single 
transfections apparently resulted in low activity of the reporter gene (values 
under 1000 units) both in normoxia and in hypoxia (Fig. 4-14 A). According to 
the FRET study (Fig. 4-3 B) and co-immunoprecipitation (Fig. 4-7), homodimer 
of HIF-2α was confirmed. However, no increase in transcription of the reporter 
gene was observed (Fig. 4-14 lanes 5 and 6), corresponding well the EMSA data 
(Fig. 4-10). Western blots of extracts from the cells confirmed efficient 
transfection of the respective single transfected HIF-subunits and the absence of 
endogenous HIF proteins (Fig. 4-14 B). 
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Fig. 4-14: Reporter gene assay after single transfection 
(A) HIF-1α, HIF-1αΔbHLH, HIF-2α, HIF-2α and HIF-2αΔbHLH were single-transfected in 
dKO U2OS cells and incubated under normoxic or hypoxic (1 % O2) conditions for 6 h. The 
values represent the average luciferase activity of three replicates with the bars indicating 
standard error. (B) The Western blot provided rough expression levels. 
 
Reporter Gene Assay after Co-Transfection 
Co-transfections were performed with HIF-1α/ARNT, HIF-
1αΔbHLH/ARNTΔbHLH, HIF-2α/ARNT, HIF-2αΔbHLH/ARNTΔbHLH, HIF-
1α/HIF-2α and HIF-1αΔbHLH/HIF-2αΔbHLH, respectively. It is obvious that 
significant transcriptional activity was observed only for two wild type 
heterocomplexes of HIF-1α/ARNT and HIF-2α/ANRT (Fig. 4-15 A, lanes 1 and 
3). Compared with the wild type complex, the bHLH-deleted complexes 
provided little activity (Fig. 4-15 A, lanes 2 and 4 compared with lanes 1 and 3), 
indicating that the DNA-binding required the bHLH domain. Additionally, the 
heterocomplexes of HIF-2α generally provided higher values than HIF-1α 
heterocomplexes in the case of U2OS cells (Fig. 4-15 A, lane 2 compared with 
lanes 1). Although the homodimers of HIF-1α/HIF-2α were observed by FRET 
and co-immunoprecipitation (Fig. 4-4 and Fig. 4-7), no considerable activity 
was observed for complexes of HIF-1α/HIF-2α or HIF-1αΔbHLH and HIF-
2αΔbHLH (Fig. 4-15 A, lanes 5 and 6), corresponding well the EMSA data of 
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Fig. 4-15. Appropriate expression levels were confirmed by Western blot (4-15 
B). 
 
 
 
 
Fig. 4-15: Reporter gene assay after co-transfection 
(A) HIF-1αΔbHLH/ARNTΔbHLH, HIF-2α/ARNT, HIF-2αΔbHLH/ARNTΔbHLH, HIF-
1α/HIF-2α and HIF-1αΔbHLH/HIF-2αΔbHLH were co-transfected in dKO U2OS cells and 
incubated under normoxic or hypoxic (1 % O2) conditions for 6 h. The values represent the 
average luciferase activity of three replicates with the bars indicating standard error. (B) The 
Western blot provided rough expression levels. 
 
PAS Study Using Reporter Gene Assay 
For PAS study, assemblies of HIF-2αPASBm./ARNT, HIF-2αΔPASAB/ARNT, 
HIF-2αΔPASAB/HIF-1α and HIF-2αΔPASAB/HIF-2α were co-transfected in 
dKO U2OS cells. Interestingly, transcriptional activity was observed for the 
HIF-2αPASBm. complex (Fig. 4-16 A), albeit on a substantially lower level 
when compared with wild type complex HIF-2α/ARNT (Fig. 4-15 A, lane 3). 
According to the FRET data of Fig. 4-5 and 4-6, no dimerization was observed 
for HIF-2α homo- or heteroassemblies in case of the absence of whole PAS 
domain. Evidently, no activity above background of HIF-2αΔPASAB/ARNT, 
HIF-2αΔPASAB/HIF-1α or HIF-2αΔPASAB/HIF-2α was detected (Fig. 4-16 A, 
lanes 2 ,3 and 4), indicating the requirement of the whole PAS domain for 
hetero- and homodimerization, specially the requirement of the wild type PAS 
B-domain for the full transcriptional activity.(Yang et al., 2005). Again, the 
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expression levels of the respective HIF-subunits were confirmed by Western 
blot (Fig. 4-16 B). 
 
 
 
 
Fig. 4-16: PAS study using reporter gene assay 
(A) HIF-2αPASBm./ARNT, HIF-2αΔPASAB/ARNT, HIF-2αΔPASAB/HIF-1α and HIF-
2αΔPASAB/HIF-2α were co-transfected in dKO U2OS cells and incubated under normoxic 
or hypoxic (1 % O2) conditions for 6 h. The values represent the average luciferase activity of 
three replicates with the bars indicating standard error. (B) The Western blot provided rough 
expression levels. 
 
4.5 CA9-Quantification Using Real Time PCR 
The homodimer of HIF-1α/HIF-2α was confirmed by FRET data (Fig. 4-3 B) 
and co-immunoprecipitation (Fig. 4-7), however provided no DNA-binding 
(Fig. 4-10) and subsequent transcription activity (Fig. 4-14 A). This allowed us 
to considerate the physiological meaning of the homodimer complexes. To 
address this question, a HIF-1α specific target gene carbonic anhydrase 9 was 
used to identify the meaning of HIF-1α/HIF-2α using real time PCR experiment. 
2 µg ANRT was first transfected into wild type U2OS cells to ensure sufficient 
dimerization partner for both HIF-1α and HIF-2α to form heterocomplexes. 
After 6 h incubation in 1 % hypoxia, accumulated endogenous HIF-1α formed 
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heterocomplex of with ARNT. A titration of HIF-2α against HIF-1α/ARNT 
complex was carried out by starting from 0 to 1.4 µg in steps of 0.2 µg plasmid 
amounts. Surprisingly, the CA9 mRNA expression level decreased almost 50 % 
already in the early stage of the 0.2 µg HIF-2α transfection, which continued 
until CA9 expression level reduced to about 20 %. With respect to the EMSA 
results in Fig. 4-11, HIF-2α was proved to inhibit the heterodimerization of HIF-
1α/ARNT by forming a DNA unbound complex HIF-1α/HIF-2α. Combining 
these results, further conclusion was made that HIF-2α in non-DNA binding 
HIF-1α/HIF-2α complexes might compete with ARNT for HIF-1α, which 
caused the reduction of HIF-1α/ARNT dependent gene expression like CA9. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-17: CA9-quantification using real time PCR 
Figure provided the mRNA level of carbonic anhydrase 9 using real time PCR. After 
transfection of ARNT, titration of HIF-2α was performed against endogenous HIF-1α induced 
in 1 % hypoxia. The values represent the average units of three replicates with the bars 
indicating standard error. 
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5. Discussion 
 
Hypoxia-inducible factors are today well known bHLH-PAS transcription 
factors, which provide a signaling pathway to sense hypoxia and respond to 
balance the O2 availability in all mammalian cells (Semenza, 2001). As a 
potential target for therapeutic approach to hypoxic tissue disease, the 
transcriptional pathway of HIF is meticulously investigated. As a result, some 
small molecules interfering either with HIF-subunit dimerization or HIF-DNA 
binding have identified and are currently tested for applicability (Key et al., 
2009, Choi et al., 2009, Lee et al., 2009, van de Sluis et al., 2010, Vinson, 2005 
and Scheuermann et al., 2009). To provide some basic insight into HIF complex 
assembly, this study aimed at examining the different contributions of bHLH 
and PAS domains to both dimerization and DNA-binding. Furthermore, we also 
examined complex formation by the highly similar isoforms HIF-1α and HIF-2α 
with ARNT. By applying modern confocal microscopic FRET, I was able to 
elucidate protein-protein interaction of HIF subunits directly in living cells, to a 
great extend mimicking physiological conditions. Our data may provide a new 
view in the study of HIF activation. 
 
5.1 The Role of the bHLH Domains 
bHLH proteins are well conserved and widespread in mammalian cells (Murre 
et al., 1994). As a member of this protein family, hypoxia inducible factor 
belongs to the class of bHLH proteins which are ubiquitously expressed and can 
form either homo- and/or heterodimers (Murre et al., 1989). The N-terminal 
region, which consists of basic residues, was identified to allow the protein to 
bind to DNA: Deletion of the conserved basic residues abrogates DNA binding 
(Davis et al., 1990). This finding was fully supported by the present study: In 
the Electro-Mobility-Shift-Assay, no clear DNA-bound complex was observed 
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after HIF-1αΔbHLH/ARNTΔbHLH co-transfection (Fig. 4-9, lanes 10 and 11), 
due to the lack of the basic region of the bHLH domain. Due to the failure to 
bind to DNA, the determination of transcriptional activity using the luciferase 
reporter gene assay revealed loss of this function (Fig. 4-15 A, lanes 2 and 4). 
The second HLH region characterized by hydrophobic residues is described to 
be involved in homo- and/or heterodimerization. Insertion of proline residues or 
mutation of the conserved hydrophobic residues obliterated the ability to form 
dimers (Davis et al., 1990). However, in the case of HIF proteins (both HIF-1 
and HIF-2), no substantial difference was observed by comparing the wildtype 
and bHLH-deleted complexes in the heterodimerization study using FRET (Fig. 
4-2 A and B). It should be noted that the bHLH domain was neither required for 
homodimerization (Fig. 4-3 B or Fig. 4-4). As potential explanation it is possible 
that in the case of bHLH and PAS domain combining proteins like HIF, the PAS 
might be more dominant both for homo- and heterodimerization.  
 
5.2 Functions of the PAS Domains 
Hypoxia inducible factors belong to the largest class of PAS proteins, which is 
known as the bHLH-PAS family consisting of bHLH, PAS-A, PAS-B and and 
C-terminal transactivation domain (Letunic et al., 2006). In the previous 
discussion of bHLH, my results emphasize that the bHLH domain contributes to 
the DNA-binding with its basic region, however, it does not substantially confer 
dimerization with its helix-loop-helix domain, implying that HIF dimerization 
might require the PAS domain with its β-sheet interfaces defining the formation 
of specific heterodimerization (Erbel et al., 2003, Card et al., 2005, Yang et al., 
2005, Scheuermann et al., 2009 and Zhu et al., 2012). To investigate the 
function of the PAS domain during dimerization, a triple-point-mutation of the 
PAS B-domain with minimal changes in the β-sheet backbone (Yang et al., 
2005) and a PAS AB-domain deletion of HIF-2α (Fig. 2-4, lower section) were 
used for FRET. Neither homo- nor heterodimerization was found using the 
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protein with mutational changes in the PAS domain (Fig. 4-5 A, B and Fig. 4-6), 
indicating that the β-sheet interfaces were indeed required both for homo- and 
heterodimerization. No further DNA bound heterocomplexes were observed in 
HIF-2αPASBm./ARNT (Fig. 4-12). Interestingly, some transcriptional activity 
was observed for the HIF-2αPASBm. complex (Fig. 4-16 A, lane 1), albeit on a 
substantially lower level when compared with wild type complex HIF-2α/ARNT 
(Fig. 4-15 A, lane 3), while no activity above background of HIF-
2αΔPASAB/ARNT was detected (Fig. 4-16 A, lane 2). This might indicate the 
requirement of the whole PAS domain for heterodimerization, specially the 
requirement of the wild type PAS B-domain for the full transcriptional activity 
(Yang et al., 2005). In addition, unlike the HIF-2α (Fig. 4-3 A), HIF-1α could 
not form homodimers (Fig. 4-3 B). Thus, it is tempting to speculate that the 
characteristics of β-sheet interfaces involving homo- and heterodimerization are 
very important and that the β-sheet in HIF-1α might be too short to form 
homodimers. 
 
5.3 The HIF-2α Homodimer 
Heterodimerization of HIF-1α and its isoform HIF-2α with the constitutive 
ARNT is required for HIF transcriptional activity. Using the common β-sheet 
interfaces, PAS domains lead to the heterodimer formation (Card et al., 2005). 
As discussed in discussion 5.2, the β-sheet interfaces might however contribute 
differently to the homodimer formation between HIF-1α and HIF-2α: only HIF-
2α homodimers were observed in FRET (Fig. 4-3 B) and confirmed by co-
immunoprecipitation (Fig. 4-7). Interestingly, however, they shared no DNA-
binding with heterodimers regardless whether the asymmetric W18 HIF binding 
site (HBS) as part of the erythropoietin enhancer or the palindromic HBS from 
Bnip3 (Fig. 4-10) were used, and apparently showed very low transcriptional 
activity (Fig. 4-14, lane 5).  
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It is widely recognized that HIF-1 and HIF-2 colocalize in tissues like the 
kidney where the typical heterodimerization pathway with ARNT is shared both 
for HIF-1α and HIF-2α to induce their specific or common target genes (Fig. 5-
1). Simultaneously, however, one may speculate about a competitive behavior: 
HIF-2α transcriptional activity might be suppressed by forming nonfunctional 
HIF-2α homodimers (Fig. 5-2). This notion might be the cause for the primary 
activation during the acute phase of hypoxic adaptation of HIF-1α and the 
secondary dominant activation during the chronic phases of HIF-2α (Holmquist-
Mengelbier et al., 2006). Furthermore, the homodimer might prevent the HIF-2α 
from translocation, hydroxylation and subsequent degradation, although the 
underlying details require additional study and proof. 
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Fig. 5-1: “Classic” heterodimeric HIF-1α and HIF-2α mediated pathway in cells 
HIF-αs accumulate in hypoxia and translocate into nuclear to dimerize with ARNT. 
Heterocomplex bind to HRE of DNA to induce HIF target genes. In normoxia, α-subunits can 
be rapidly hydroxylated, unbiquitinylated and proteasomal degraded. 
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Fig. 5-2: HIF-2α suppressed its activity by forming homodimer 
Within the nucleus, the HIF-2α transcriptional activity was suppressed by forming HIF-2α 
homodimers. The homodimer might also prevent the translocation and proteasomal 
degradation of HIF-2α. 
 
5.4 The Role HIF-1α/HIF-2α Homodimers 
Since the identification of the two isoforms HIF-1α and HIF-2α a number of 
studies about their similarity have been performed, also aimed at defining 
specific roles. Both of them are highly conserved at the protein level, sharing a 
similar protein structure and several common target genes like VEGF (Loboda 
et al., 2010). However, clear cell renal carcinoma proliferation is retarded by 
HIF-1α, but induced by HIF-2α (Xu et al., 2011). Nevertheless HIF-1α alone is 
universally associated with the induction of pro-oncogenic features like tumor 
angiogenesis via VEGF (Jiang et al., 1997). As an opposite example, in 
mammary carcinoma, HIF-1α was required for induction of a set of well-
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characterized hypoxic genes in breast carcinoma cell lines, while HIF-2α 
inhibited the growth of the tumor cells (Blancher et al., 2000). The existence of 
the two isoforms and the diametrically opposed behavior raises the question 
whether they have in general control similar or even contrasting effects? 
Interestingly, in this study, FRET data manifestly revealed the 
homodimerization of HIF-1α/HIF-2α (Fig. 4-4), supported by co-
immunoprecipitation experiment (Fig. 4-7). Still, no DNA-binding of the 
homodimeric complex (Fig. 4-11) and no considerable transcriptional activity 
(Fig. 4-15, lane 5) were observed. Most interestingly, it should be noted that 
HIF-2α overexpression inhibited HIF-1α to heterodimerize with ARNT by 
forming a DNA unbound complex HIF-1α/HIF-2α (Res. 4-3, Fig. 4-11). In 
support of this finding, the HIF-1α specific target gene carbonic anhydrase 9 
mRNA expression level decreased considerably when cell were transfected to 
overexpress HIF-2α (Fig. 4-17). From these findings one may assume 
competition between ARNT – which was also abundant due to overexpression – 
and HIF-2α for HIF-1α: forming a HIF-1α/HIF-2α homodimer in a scenario of 
HIF-2α abundance could negatively regulate and thus fine-tune the expression 
of a HIF-1α/ARNT controlled gene such as CA9 (Fig. 5-3). 
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Fig. 5-3: Competition mechanism of HIF-1α and HIF-2α 
In cell with both HIF-1α and HIF-2α, either subunit dimerized with ARNT can induce 
specific target genes or share common target genes. This was however prevented by forming 
a nonfunctional homodimer of HIF-1α/HIF-2α. 
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7.1 List of Abbreviations 
Table 7-1 List of abbreviations 
Abbreviations full name 
HIF hypoxia inducible factor 
FRET fluorescence resonance energy transfer 
bHLH basic-helix-loop-helix 
PAS Period/Arnt/Single-minded 
ARNT aryl hydrocarbon nuclear translocator 
ODD oxygen-dependent degradation 
TAD transactivation domain 
PHD prolyl hydroxylase-domain 
NLS nuclear localization sequence 
HBS HIF binding site 
HRE hypoxia response elements 
CA9 carbonic anhydrase 9 
VEGF vascular endothelial growth factor 
ADM adrenomedullin 
EPO erythropoietin 
CBP cAMP response element binding protein 
FIH factor inhibiting HIF 
Bnip BCL2/adenovirus E1B interacting protein 
PGK phosphoglycerate kinase 
ROS reactive oxygen species 
EMSA Electro-Mobility-Shift assay 
EDTA ethylenediaminetetraacetic acid 
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PBS phosphate buffered saline 
SDS sodium dodecyl sulfate 
TEMED tetramethylethylenediamine 
APS ammonium persulfate 
Tris tris(hydroxymethyl)aminomethane 
TBS-T tris-buffered saline-Tween 
GFP freen fluorescent protein 
CFP cyan fluorescent protein 
YFP yellow Fluorescent Protein 
DTT dithiothreitol 
GTC guanidium thiocyanate 
DEPC diethylpyrocarbonate 
RT reverse transcription 
PCR polymerase chain reaction 
qRT quantitative real time 
UV ultraviolet 
IHF Integration Host Factor 
Int integrase 
Xis excisionase 
Cm (R) chloramphenicol resistance 
PNK polynucleotide kinase 
TAE tris acetate-EDTA 
DMEM Eagle's minimal essential medium 
FCS fetal calf serum 
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Fig. 4-9: The role of the bHLH domain for DNA binding 
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7.4 List of Cloned Plasmids 
Table 7-2 List of cloned plasmids 
pExp-YFP-ARNTΔbHLH 
pExp-YFP-hARNT delta bHLH
8085 bp
Ampicillin
Blasticidin
attB1
attB2
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
Kozak consensus sequence
seq compl okay
seq direct okay
Primer 4for
Primer 3for
Primer 2for
Primer 1for
Primer 1rev
Primer 2rev
Primer 3rev
Primer 4rev
EGFP-C SeqPrimer
SV40ori
CMV
EM7
pUC ori
YFP
hARN T
 
pExp-CFP-HIF-2αΔPASAB 
pExp-CFP-hHIF2adelta PASAB
7741 bp
Ampicillin
Blast icidin
attB1 attB2CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylat ion signal
TK pA
V5
HIF2adelta PASAB
SV40ori
CMV
EM7
pUC ori
 
pExp-CFP-HIF-2αPASBm. 
pExp-CFP-hHIF2aPASBm.
8524 bp
Ampicillin
Blasticidin
attB1 attB2
CFP
Amp promotor (bla)
SV40 pA
f1 ori
TK polyadenylation signal
TK pA
V5 HIF2aPASBm.
SV40ori
CMV
EM7
pUC ori
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